Clinical Trial Update: Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating trimethoprim/sulfamethoxazole combined with caspofungin as first-line therapy for Pneumocystis pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumocystis Pneumonia

Drugs mentioned

• Caspofungin (caspofungin)
• Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Bin Du | Conditions: Pneumocystis Pneumonia | Phase 4 | Status: UNKNOWN